Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000284:Administration, Oral; D000527:Alprostadil / Q000031:analogs & derivatives*; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D003094:Collagen / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D011458:Prostaglandins E / Q000494:pharmacology; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D014664:Vasodilation / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D014667:Vasopressins; D000244:Adenosine Diphosphate; C025090:ONO 1206; D003094:Collagen; D000527:Alprostadil